logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

City Therapeutics Appoints Andrew Orth As Chief Executive Officer

Jan 07, 2025•12 months ago

Position

Chief Executive Officer

Company

City Therapeutics

Andrew Orth
CambridgeTherapeuticsBiotechnologyHealth Care

Description

City Therapeutics, Inc announced the appointment of Andrew “Andy” Orth as chief executive officer and director. With more than 25 years of experience in biopharmaceutical research, development, and commercialization, Mr Orth will lead the company as it advances into the clinical and commercial stages of development, focusing on breakthrough therapeutic innovations for a range of diseases.

Company Information

Company

City Therapeutics

Location

Cambridge, Massachusetts, United States

About

City Therapeutics is a biopharmaceutical company harnessing next-generation engineering of RNAi trigger molecules to improve and expand the reach of RNAi-based medicines. The company is building a pipeline of innovative RNAi therapeutics to make a significant impact for patients across multiple therapeutic areas. Co-founded by pioneering executives and scientists in RNAi, City Therapeutics is based in Cambridge, MA, and has raised $135 million from leading life sciences investors.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months